News Releases
Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections
June 30, 2026 - New IP covers topical rose bengal sodium ophthalmic composition against MRSA and other resistant Gram-positive bacteria without requiring light activation. VisiRose to hold exclusive ophthalmic license.
Light-activated small molecule could transform eye infection treatment
April 22, 2026 - Many contact lens users occasionally fall asleep with their lenses in. However, this can cause dry and irritated eyes and blurry vision, which may be a sign of a serious infection.